Zanubrutinib relaps yoki refrakter follikulyar limfoma uchun USFDA tomonidan tasdiqlangan.

March 2024: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) in combination with obinutuzumab has been granted accelerated approval by the Food and Drug Administration for the treatment of relapsed or refractory follicular lymphoma (FL)..

Lenfoma davolashda immunoterapiyaning roli

If you're reading this, you or maybe one of your loved ones is on a journey that no one ever plans to take—the path of facing cancer. We understand that this road is filled with uncertainties, fears, and moments when it feel..

CAR - T Uyali terapiya, CAR T terapiyasi, CAR T-hujayrasi, kimerik agent

CAR T hujayra terapiyasiga chuqur sho'ng'ish: u qanday ishlaydi?

Hindistonda CAR T Cell terapiyasini davolash haqidagi fanni kashf eting! Ushbu inqilobiy davolash sizning immunitet hujayralaringizni saraton kasalligiga qarshi kurashuvchiga aylantirishini o'rganing. Ushbu mo''jizaviy terapiya va qanday qilib .. haqida ko'proq ma'lumot olish uchun bizning blogimizni o'qing.

CAR T-hujayrasi, AVTO terapiyasi, immünoterapi, T hujayrali terapiya

Hindistonda CAR T-hujayra terapiyasi mavjudmi?

Siz hech o'ylab ko'rganmisiz, saraton bilan kurashishning kuchli usuli bormi? Tasavvur qiling-a, bir kun kelib siz saraton kasalligiga qarshi kurashda umid nurini topdingiz, bu sizning tanangizning immunitet tizimining kuchidan foydalanib, saraton kasalligiga qarshi kurashda.

B-hujayrali limfoma, DLBCL, POLARIX, Polatuzumab, polatuzumab vedotin

Polatuzumab vedotin-piiq ilgari davolanmagan diffuz yirik B hujayrali limfoma va yuqori darajali B hujayrali limfoma uchun USFDA tomonidan tasdiqlangan.

2023 yil may: Yuqori darajali B-hujayrali limfomasi (HGBL), boshqacha ko'rsatilmagan (NOS) yoki diffuz yirik B hujayrali limfomasi (DLBCL) bo'lgan, ilgari davolanmagan va Xalqaro prognostik ko'rsatkichga ega bo'lgan kattalar uchun.

Karteyva, JW Therapeutics, limfoma, refrakter follikulyar limfoma, RELIANCE tadqiqoti, relmacabtagene autoleucel

JW Therapeutics relapslangan yoki refrakter follikulyar limfoma bilan og'rigan bemorlarga Relmacabtagene Autoleucel in'ektsiyasini NMPA ma'qullaganini e'lon qiladi.

SHANGHAI, CHINA, October 10, 2022 - JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing, and commercializing cell immunotherapy products, announced that the Na..

ASTCT, CIBMTR, Katta B hujayrali limfoma, Metyu Frank, Miltenyi Biotec, Stenford universiteti

CAR-T terapiyasidan keyin qayt qilgan limfomali bemorlar uchun yangi davolash maqsadi

Feb 2023: The results of the trial demonstrated that a novel chimeric antigen receptor T-cell therapy elicited a response in adults with advanced large B-cell lymphoma who had relapsed following prior CAR-T. According to stati..

Eli Lilly va Kompaniya, FDA, Oziq-ovqat va dori-darmonlarni boshqarish, Jaypirca, Mantiya hujayralari lenfoma, MCLlar, pirtobrutinib

Tezlashtirilgan ruxsat FDA tomonidan pirtobrutinibga relapsli yoki refrakter mantiya hujayrali lenfoma uchun beriladi.

Feb 2023: Accelerated approval is granted by FDA to pirtobrutinib (Jaypirca, Eli Lilly and Company) for relapsed or refractory mantle cell lymphoma. In BRUIN (NCT03740529), an open-label, multicenter, single-arm trial of pirtobr..

BeiGene AQSh, BRUKINSA, surunkali limfotsitik leykemiya, SEQUOYA, kichik limfotsitik limfoma

Zanubrutinib FDA tomonidan surunkali limfotsitik leykemiya yoki kichik limfotsitik limfoma uchun tasdiqlangan.

Feb 2023: Zanubrutinib (Brukinsa, BeiGene USA, Inc.) is approved by FDA for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). SEQUOIA was used to assess effectiveness in CLL/SLL patients who had not recei..

Siz yetib olasiz, brentuximab vedotin, klassik Xodgkin limfomasi, Seagen Inc.

Brentuximab vedotin FDA tomonidan klassik Xodgkin limfomasi bo'lgan bolalar uchun kimyoterapiya bilan birgalikda tasdiqlangan.

2022-yil noyabr: Doksorubitsin, vinkristin, etoposid, prednizon va siklofosfamidning brentuksimab vedotin (Adcetris, Seagen, Inc.) bilan kombinatsiyasi Oziq-ovqat va farmatsevtika idorasi tomonidan bolalarda foydalanish uchun tasdiqlangan.